These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24820923)

  • 1. Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.
    Droogne W; Jacobs S; Van den Bossche K; Verhoeven J; Bostic RR; Vanhaecke J; Van Cleemput J; Rega F; Meyns B
    Acta Clin Belg; 2014 Jun; 69(3):165-70. PubMed ID: 24820923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison of heart transplant vs. left ventricular assist device therapy at one year.
    Marasco SF; Summerhayes R; Quayle M; McGiffin D; Luthe M
    Clin Transplant; 2016 May; 30(5):598-605. PubMed ID: 26913688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs Before and After Left Ventricular Assist Device Implant and Preceding Heart Transplant: A Cohort Study.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton PJ; Saing S; Hayward C
    Heart Lung Circ; 2020 Sep; 29(9):1338-1346. PubMed ID: 32371031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
    Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
    Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric heart transplant candidates with failed donor heart allocation after Eurotransplant urgency listing profit from pretransplant mechanical circulatory support bridging.
    Komoda T; Lehmkuhl HB; Stiller B; Berger F; Hetzer R
    Artif Organs; 2009 Apr; 33(4):346-51. PubMed ID: 19335411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and cost effectiveness of the mechanical and pharmacologic bridge to transplantation.
    Loisance D; Benvenuti C; Lebrun T; Leclerc A; Tarral A; Sailly JC
    ASAIO Trans; 1991; 37(3):M125-7. PubMed ID: 1836332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
    Chew DS; Manns B; Miller RJH; Sharma N; Exner DV
    Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation versus continuous-flow left ventricular assist device: comprehensive cost at 1 year.
    Patel SR; Sileo A; Bello R; Gunda S; Nguyen J; Goldstein D
    J Card Fail; 2015 Feb; 21(2):160-6. PubMed ID: 25433361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.